---
title: "NKGN.US (NKGN.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/NKGN.US/news.md"
symbol: "NKGN.US"
name: "NKGN.US"
parent: "https://longbridge.com/zh-HK/quote/NKGN.US.md"
datetime: "2026-03-18T05:07:48.848Z"
locales:
  - [en](https://longbridge.com/en/quote/NKGN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NKGN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NKGN.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/NKGN.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/NKGN.US/news.md)


# NKGN.US (NKGN.US) — 相關新聞

### [Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms | KNBIF Stock News](https://longbridge.com/zh-HK/news/279420818.md)
*2026-03-17T03:25:42.000Z*
> Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant

### [Genscript Biotech Books 2025 Loss Despite 61% Growth in Revenue](https://longbridge.com/zh-HK/news/279196867.md)
*2026-03-16T03:25:35.000Z*
> Genscript Biotech Books 2025 Loss Despite 61% Growth in Revenue

### [NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimer’s Disease at AD/PD™ 2026 | NKGN Stock News](https://longbridge.com/zh-HK/news/278551820.md)
*2026-03-10T04:06:43.000Z*
> NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimer’s Disease at AD

### [Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership | KNBIF Stock News](https://longbridge.com/zh-HK/news/278545247.md)
*2026-03-10T03:25:00.000Z*
> Kane Biotech Inc. has announced a strategic distribution partnership with Marathon Medical Corporation to enhance its U.

### [Kane Biotech expands in US with distribution deals for revyve Antimicrobial Wound Gel product line with companies in Texas and New Jersey.](https://longbridge.com/zh-HK/news/276333671.md)
*2026-02-19T12:27:02.000Z*
> Kane Biotech Inc. has announced distribution deals for its revyve® Antimicrobial Wound Gel® with Patient Care Medical in

### [Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser | KNBIF Stock News](https://longbridge.com/zh-HK/news/276123113.md)
*2026-02-17T04:25:00.000Z*
> Kane Biotech Inc. has received FDA 510(k) clearance for its revyve® Antimicrobial Skin and Wound Cleanser, enhancing its

### [Kane Biotech Restarts Commercial Activities and Strengthens North American Management | KNBIF Stock News](https://longbridge.com/zh-HK/news/275755589.md)
*2026-02-12T04:25:00.000Z*
> Kane Biotech Inc. has resumed commercial activities for its revyve® Antimicrobial Wound Gel in the U.S. and Canada, appo

### [NKGen Biotech Secures Additional $251,000 in Loan Amendment with AlpineBrook Capital](https://longbridge.com/zh-HK/news/275040845.md)
*2026-02-05T22:26:05.000Z*